While there are preclinical studies suggesting that HMGCR inhibitors alone, or in combination with other drugs, effectively inhibit melanoma cell growth45,46, the usefulness of statins for melanoma patients is still controversial47–49. The gene discussed is HMGCR; the disease is melanoma.